دورية أكاديمية

Neurological Consequences of Pulmonary Emboli in COVID-19 Patients: A Study of Incidence and Outcomes in the Kingdom of Saudi Arabia.

التفاصيل البيبلوغرافية
العنوان: Neurological Consequences of Pulmonary Emboli in COVID-19 Patients: A Study of Incidence and Outcomes in the Kingdom of Saudi Arabia.
المؤلفون: Bakhsh E; Clinical Sciences Department, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia., Shaban M; Community Health Nursing Department, College of Nursing, Jouf University, Sakaka 72388, Saudi Arabia., Alzoum MA; King Abdullah bin Abdulaziz University Hospital, Riyadh 11552, Saudi Arabia., AlNassir AM; King Abdullah bin Abdulaziz University Hospital, Riyadh 11552, Saudi Arabia., Bin Hamad AA; King Abdullah bin Abdulaziz University Hospital, Riyadh 11552, Saudi Arabia., Alqahtani MS; King Abdullah bin Abdulaziz University Hospital, Riyadh 11552, Saudi Arabia., AlAyoubi LAF; King Abdullah bin Abdulaziz University Hospital, Riyadh 11552, Saudi Arabia., Alamri RM; King Abdullah bin Abdulaziz University Hospital, Riyadh 11552, Saudi Arabia., Alamri NF; Cardiothoracic Imaging Department, King Fahad Medical City, Riyadh 11525, Saudi Arabia.
المصدر: Brain sciences [Brain Sci] 2023 Feb 17; Vol. 13 (2). Date of Electronic Publication: 2023 Feb 17.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101598646 Publication Model: Electronic Cited Medium: Print ISSN: 2076-3425 (Print) Linking ISSN: 20763425 NLM ISO Abbreviation: Brain Sci Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI
مستخلص: Pulmonary embolism (PE) is a significant consequence that is becoming more common in COVID-19 patients. The current study sought to determine the prevalence and risk factors for PE in a study population of COVID-19 patients, as well as the relationship between PE and neurological sequelae. The research also sought to analyze the consistency of neurological examination and imaging techniques in detecting neurological problems. The research comprised a total of 63 individuals with COVID-19. The incidence of PE in the study group was 9.5% for smokers, 23.8% for obese patients, 33.3% for hypertensive patients, and 19% for diabetic patients, according to the findings. After adjusting for possible confounders such as age, gender, BMI, smoking, hypertension, and diabetes, a logistic regression analysis indicated that the probabilities of having neurological complications were 3.5 times greater in individuals who had PE. In conclusion, the present study highlights the high incidence of PE among patients with COVID-19 and the association between PE and neurological complications. The study also emphasizes the importance of a thorough neurological examination and imaging studies in the detection of neurological complications in patients with PE.
References: J Stroke Cerebrovasc Dis. 2022 Jan;31(1):106163. (PMID: 34763262)
J Neurol Sci. 2020 Oct 15;417:117085. (PMID: 32871412)
J Stroke Cerebrovasc Dis. 2021 Jun;30(6):105733. (PMID: 33743411)
J Clin Med. 2020 Jun 05;9(6):. (PMID: 32516940)
J Saudi Heart Assoc. 2020 May 06;33(2):128-134. (PMID: 34183909)
Neurol Int. 2021 Mar 09;13(1):102-119. (PMID: 33803475)
Brain. 2012 Feb;135(Pt 2):320-44. (PMID: 22067541)
Cells. 2020 Oct 27;9(11):. (PMID: 33120941)
Nat Med. 2021 Apr;27(4):601-615. (PMID: 33753937)
Lancet Respir Med. 2021 Jan;9(1):107-116. (PMID: 33217366)
Neurol Neurochir Pol. 2022;56(2):148-155. (PMID: 35118638)
Mol Neurobiol. 2021 Jul;58(7):3417-3434. (PMID: 33715108)
J Intern Med. 2016 Jan;279(1):16-29. (PMID: 26286356)
Cureus. 2022 Aug 3;14(8):e27633. (PMID: 36072173)
J Neurointerv Surg. 2021 Mar;13(3):202-206. (PMID: 33298508)
Cell. 2020 Oct 1;183(1):16-27.e1. (PMID: 32882182)
Front Microbiol. 2021 Jun 23;12:698169. (PMID: 34248921)
Korean Circ J. 2018 May;48(5):365-381. (PMID: 29737640)
Int J Environ Res Public Health. 2020 Nov 24;17(23):. (PMID: 33255233)
J Thromb Thrombolysis. 2021 Jan;51(1):40-46. (PMID: 32613385)
Semin Vasc Surg. 2021 Sep;34(3):101-116. (PMID: 34642030)
Cureus. 2020 Aug 3;12(8):e9540. (PMID: 32905500)
Mayo Clin Proc. 2009;84(1):91-2. (PMID: 19121259)
Nat Med. 2022 Nov;28(11):2406-2415. (PMID: 36138154)
Methodist Debakey Cardiovasc J. 2020 Apr-Jun;16(2):155-157. (PMID: 32670476)
Sci Rep. 2021 Aug 6;11(1):16025. (PMID: 34362946)
Nat Rev Immunol. 2022 Nov;22(11):657-673. (PMID: 35246670)
Curr Neurol Neurosci Rep. 2021 Oct 20;21(10):59. (PMID: 34669060)
Front Immunol. 2022 May 18;13:878771. (PMID: 35663989)
Thromb Res. 2021 Jan;197:94-99. (PMID: 33190025)
Int J Mol Sci. 2021 Apr 15;22(8):. (PMID: 33920904)
J Am Heart Assoc. 2013 Nov 25;2(6):e000372. (PMID: 24275627)
Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620962853. (PMID: 33074732)
Neurocrit Care. 2021 Jun;34(3):1062-1071. (PMID: 32661794)
AJNR Am J Neuroradiol. 2002 Apr;23(4):716-23. (PMID: 11950675)
Clin Imaging. 2021 Sep;77:244-249. (PMID: 34029929)
Int J Mol Sci. 2017 Dec 06;18(12):. (PMID: 29211044)
Immunology. 2018 Jun;154(2):204-219. (PMID: 29513402)
SN Compr Clin Med. 2022;4(1):90. (PMID: 35402784)
Ann Intensive Care. 2020 Sep 16;10:124. (PMID: 32953201)
Thromb Res. 2020 Oct;194:101-115. (PMID: 32788101)
فهرسة مساهمة: Keywords: COVID-19; neurological complications; pulmonary embolism
تواريخ الأحداث: Date Created: 20230225 Latest Revision: 20230228
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9954757
DOI: 10.3390/brainsci13020343
PMID: 36831886
قاعدة البيانات: MEDLINE
الوصف
تدمد:2076-3425
DOI:10.3390/brainsci13020343